SE500219C2 - Humana granulocytproteiner - Google Patents

Humana granulocytproteiner

Info

Publication number
SE500219C2
SE500219C2 SE8403630A SE8403630A SE500219C2 SE 500219 C2 SE500219 C2 SE 500219C2 SE 8403630 A SE8403630 A SE 8403630A SE 8403630 A SE8403630 A SE 8403630A SE 500219 C2 SE500219 C2 SE 500219C2
Authority
SE
Sweden
Prior art keywords
proteins
protein
buffer
antisera
salts
Prior art date
Application number
SE8403630A
Other languages
English (en)
Swedish (sv)
Other versions
SE8403630L (sv
SE8403630D0 (sv
Inventor
Magne K Fagerhol
Inge Dale
Inger Naesgaard
Original Assignee
Magne K Fagerhol
Inge Dale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magne K Fagerhol, Inge Dale filed Critical Magne K Fagerhol
Publication of SE8403630D0 publication Critical patent/SE8403630D0/xx
Publication of SE8403630L publication Critical patent/SE8403630L/xx
Publication of SE500219C2 publication Critical patent/SE500219C2/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57426—Specifically defined cancers leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE8403630A 1983-07-11 1984-07-09 Humana granulocytproteiner SE500219C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838318754A GB8318754D0 (en) 1983-07-11 1983-07-11 Human proteins anti-sera test kits

Publications (3)

Publication Number Publication Date
SE8403630D0 SE8403630D0 (sv) 1984-07-09
SE8403630L SE8403630L (sv) 1985-01-12
SE500219C2 true SE500219C2 (sv) 1994-05-09

Family

ID=10545560

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8403630A SE500219C2 (sv) 1983-07-11 1984-07-09 Humana granulocytproteiner

Country Status (11)

Country Link
US (1) US4833074A (de)
JP (2) JPH0784479B2 (de)
BE (1) BE900119A (de)
CH (1) CH661048A5 (de)
DE (1) DE3425186C2 (de)
DK (1) DK169439B1 (de)
FR (1) FR2550205B1 (de)
GB (2) GB8318754D0 (de)
IT (1) IT1177889B (de)
NL (1) NL192456C (de)
SE (1) SE500219C2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0263072B1 (de) * 1986-10-03 1994-03-23 Ciba-Geigy Ag Lymphokin-ähnliche Peptide
JPH023698A (ja) * 1988-06-20 1990-01-09 Denki Kagaku Kogyo Kk ヒトリンホトキシンに対するモノクローナル抗体及びそれら抗体を産生するハイブリドーマ、並びにそれら抗体を用いたヒトリンホトキシンの精製方法、測定方法及び測定試薬
US5211937A (en) * 1990-07-30 1993-05-18 Glycomed Incorporated Method of determining a site of inflammation utilizing elam-1 ligands
US5776348A (en) * 1995-02-07 1998-07-07 Massachusetts Institute Of Technology Mineral precipitation system and method for inhibiting mineral precipitate formation
EP0937259B1 (de) 1996-11-01 2004-10-06 Magne K. Fagerhol Verfahren zur proteinextraktion
ZA981370B (en) * 1997-02-20 1998-09-07 Cerberus Developments Bv Method and apparatus for continuous flow isoelectric focusing for purifying biological substances
ES2302383T3 (es) * 1998-07-22 2008-07-01 Sapporo Breweries Ltd. Metodos para obtener anticuerpos contra las bacterias del acido lactico que deterioran la cerveza y su uso diagnostico.
GB0229747D0 (en) * 2002-12-20 2003-01-29 Axis Shield Asa Assay
DE602004017148D1 (de) 2003-03-28 2008-11-27 Univ Laval S100 protein als aktivator neutrophiler zellen zur verminderung der neutropenie bei der krebsbehandlung
MX2007000956A (es) * 2004-07-23 2007-06-05 Aspenbio Pharma Inc Metodos y dispositivos para diagnosis de apendicitis.
US7659087B2 (en) * 2004-07-23 2010-02-09 Aspenbio Pharma, Inc. Methods and devices for diagnosis of appendicitis
US20110212104A1 (en) * 2008-11-03 2011-09-01 Schering Corporation Inflammatory bowel disease biomarkers and related methods of treatment
AU2011247567B2 (en) * 2010-04-29 2014-06-19 Takeda Pharmaceutical Company Limited Purification method for divalent cation binding proteins on anion exchange resin
RU2018113694A (ru) 2015-09-17 2019-10-17 Эмджен Инк. Прогноз клинического ответа на антагонисты ил-23 с использованием биомаркеров сигнального пути ил-23
WO2017112536A1 (en) 2015-12-22 2017-06-29 Amgen Inc. Ccl20 as a predictor of clinical response to il23-antagonists
US11714082B2 (en) 2017-05-09 2023-08-01 Immundiagnostik Ag Method for determination of members of the S100 family of calcium binding proteins by immunoturbidimetry

Also Published As

Publication number Publication date
CH661048A5 (de) 1987-06-30
SE8403630L (sv) 1985-01-12
FR2550205A1 (fr) 1985-02-08
NL192456C (nl) 1997-08-04
DK338484A (da) 1985-01-12
JP2558442B2 (ja) 1996-11-27
GB2143239A (en) 1985-02-06
BE900119A (fr) 1985-01-09
DK169439B1 (da) 1994-10-31
GB2143239B (en) 1987-11-11
JPH0784479B2 (ja) 1995-09-13
IT8448540A0 (it) 1984-07-10
DK338484D0 (da) 1984-07-10
JPH07278194A (ja) 1995-10-24
DE3425186A1 (de) 1985-01-24
GB8318754D0 (en) 1983-08-10
SE8403630D0 (sv) 1984-07-09
US4833074A (en) 1989-05-23
FR2550205B1 (fr) 1989-12-08
NL8402182A (nl) 1985-02-01
JPS6051113A (ja) 1985-03-22
IT1177889B (it) 1987-08-26
DE3425186C2 (de) 1995-04-20
GB8417338D0 (en) 1984-08-08
NL192456B (nl) 1997-04-01

Similar Documents

Publication Publication Date Title
Peterson et al. Differentiation of glomerular, tubular, and normal proteinuria: determinations of urinary excretion of β 2-microglobulin, albumin, and total protein
US4468457A (en) Method for producing a CSAp tryptic peptide and anti-CSAp antibodies
Lin et al. Characterization of four human pregnancy-associated plasma proteins
zum Büschenfelde et al. LM-Ag and LSP--two different target antigens involved in the immunopathogenesis of chronic active hepatitis?
SE500219C2 (sv) Humana granulocytproteiner
US4514506A (en) Method for the identification and purification of human lung tumor-associated antigens (hLTAA) and clinical detection and determination of these antigens
Manni et al. The eighth component of human complement (C8): isolation, characterization, and hemolytic efficiency
Behrens et al. Studies on “Liver-Specific” Antigens: I. Evaluation of the Liver Specificity of “LSP” and “LP-2”
US4626355A (en) Method of determining alcohol consumption
US4191533A (en) Pregnancy-specific β1 -glycoprotein and process for isolating it
IE47092B1 (en) New glycoprotein and process for isolating it
US4302385A (en) Placenta-specific tissue protein PP10
US4500451A (en) New protein PP13 extracted from human placental tissues and use thereof
US4223002A (en) Isolation of alpha1 -fetoprotein
US4592863A (en) Protein PP20, a process for obtaining it, and its use
US4325866A (en) Protein, PP11, a process for its preparation and its use
Myerowitz et al. Isolation and characterization of mouse serum alpha 1-antitrypsins
Calvert et al. Properties of two pig low density lipoproteins prepared by zonal ultracentrifugation
US3979507A (en) Diagnostic system for organ abnormalities
US4599318A (en) Tissue protein PP19, a process for obtaining it, and its use
US4195073A (en) Radioimmunoassay of alpha 1 fetoprotein
Hanna et al. Detection, separation and characterization of organ specific antigens of human thrombocytes
Veltri et al. A human tumour-associated membrane antigen from squamous-cell carcinoma of the lung
SU1363564A1 (ru) Способ получени эхинококкового диагностического антигена дл иммуноферментного анализа
JP2752684B2 (ja) ヒラタケの子実体由来の溶血性蛋白質

Legal Events

Date Code Title Description
NUG Patent has lapsed